Cargando…
Pain control and reduction of opioid use associated with intracameral phenylephrine1.0%–ketorolac 0.3% administered during cataract surgery
PURPOSE: To compare pain and the need for the opioid fentanyl use associated with the administration of phenylephrine 1.0%–ketorolac 0.3% (P/K) with those of epinephrine administration during cataract surgery. SETTING: Ambulatory surgery center. DESIGN: Single-center, prospective, randomized, double...
Autores principales: | Donnenfeld, Eric D., Mychajlyszyn, Daniel, Mychajlyszyn, Andrey, Stein, Rebecca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232285/ https://www.ncbi.nlm.nih.gov/pubmed/34860481 http://dx.doi.org/10.1097/j.jcrs.0000000000000855 |
Ejemplares similares
-
Effect Of Intracameral Phenylephrine And Ketorolac 1.0%/0.3% On Intraoperative Pain And Opioid Use During Cataract Surgery
por: Donnenfeld, Eric D, et al.
Publicado: (2019) -
Visual outcomes, efficacy, and surgical complications associated with intracameral phenylephrine 1.0%/ketorolac 0.3% administered during cataract surgery
por: Rosenberg, Eric D, et al.
Publicado: (2017) -
Comparison of the frequency of use of a pupil expansion device with and without an intracameral phenylephrine and ketorolac injection 1%/0.3% at the time of routine cataract surgery
por: Bucci, Frank A, et al.
Publicado: (2017) -
Crystalline Lens Staining with Intracameral Phenylephrine During Cataract Surgery
por: Tsatsos, Michael, et al.
Publicado: (2021) -
Intracameral ketorolac concentration at the beginning and end of cataract surgery following preoperative topical ketorolac administration
por: Katsev, Douglas A, et al.
Publicado: (2017)